Cutaneous Lupus Erythematosus (CLE) is a clinically diverse group of autoimmune skin
diseases with shared histological features of interface dermatitis and autoantibodies …

Systemic lupus erythematosus (SLE), often known simply as lupus, is a severe chronic
autoimmune disease that is characterized by multi-organ and tissue damage and high levels …

Cutaneous lupus erythematosus (CLE) is a common manifestation of systemic lupus
erythematosus (SLE), and CLE can also develop without systemic involvement. CLE can be …

Dysregulation in the phenotype and function of neutrophils may play important roles in the
initiation and perpetuation of autoimmune responses, including conditions affecting the skin …

Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disorder
characterized by high autoantibodies levels and multiorgan tissue damage. The current …

Abstract [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (CIM) has been used
as a bioactive agent for inhibiting tumor growth and angiogenesis via mitogen-activated …

Leptin is the forerunner of the adipokine superfamily and plays a key role in regulating
energy expenditure and neuroendocrine function. Researches into leptin put emphasize not …

Moderate-to-severe systemic lupus erythematosus (SLE) is characterized by extensive
autoantibody deposition and persistent autoinflammation. As the existing animal models are …

Glucocorticoid-induced osteoporosis (GIOP) is a severe and common complication of long-
term usage of glucocorticoids (GCs) and lacks of efficient therapy. Here, we investigated the …

Cutaneous lupus erythematosus (CLE) is an inflammatory and autoimmune skin condition
that affects patients with systemic lupus erythematosus (SLE) and exists as an isolated entity …